Business

April 1, 2014

Heat Biologics reports wider net loss in 2013

Heat Biologics reported a wider net loss in 2013 that it attributed to an increase in both research and development and clinical and regulatory expenses.

Related content

Comments

Videos

Editor's Choice Videos